必健利注射劑

Negara: Taiwan

Bahasa: China

Sumber: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Bahan aktif:

EACH SOLVENT CONTAINS;;TOCOPHEROL ALPHA-;;FRUCTOSE DIPHOSPHATE CALCIUM SALT;;ADENOSINE TRIPHOSPHATE SODIUM;;LIDOCAINE HCL;;EMBRYONAL HEART EXTRACT;;GLUCOSE;;COCARBOXYLASE (THIAMINE PYROPHOSPHATE)

Tersedia dari:

禾利行股份有限公司 台北巿敦化北路３１１號４Ｆ (03126405)

Bentuk farmasi:

凍晶注射劑

Komposisi:

EMBRYONAL HEART EXTRACT (2008001300) (1:400) 10MG; FRUCTOSE DIPHOSPHATE CALCIUM SALT (4020000620) 100MG; GLUCOSE (4020000700) 100MG; LIDOCAINE HCL (7200001010) 25MG; COCARBOXYLASE (THIAMINE PYROPHOSPHATE) (8810100200) 25MG; TOCOPHEROL ALPHA- (8820000110) 10MG; ADENOSINE TRIPHOSPHATE SODIUM (9200000331) 10MG; EACH SOLVENT CONTAINS (9800001300) 2ML

Unit dalam paket:

安瓿附溶液

Kelas:

製　劑

Jenis Resep:

限由醫師使用

Diproduksi oleh:

POLI INDUSTRIA CHEMICA S.P.A. VIA VOLTURNO N.45/48-20089 QUINTO DE'STAMPI ROZZA MILAN,ITALYVIA MARCORA 11-20121 MILAN,ITALY IT

Indikasi Terapi:

心肌梗塞、肌萎縮症、冠狀動脈機能不全、狹心症、病後及手術後之恢復

Ringkasan produk:

註銷日期: 1987/02/27; 註銷理由: 未參加評估（一）; 有效日期: 1985/12/31; 英文品名: PERCUORE

Status otorisasi:

已註銷

Tanggal Otorisasi:

1972-01-17